SCHEMBL25629874

SCHEMBL25629874

COc1ccc(Cn2cc(C)c(S(=O)ON)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ AADAT Q8N5Z0 1/20 0.43
▸ PTGS2 P35354 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ CMA1 P23946 1/20 0.41
▸ GSK3A P49840 1/20 0.39
▸ GSK3B P49841 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.38
▸ HSP90AB1 P08238 1/20 0.38
▸ DCTPP1 Q9H773 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ KLKB1 P03952 1/20 0.37
▸ CACNA1G O43497 1/20 0.37
▸ CACNA1H O95180 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28515551 0.86 MEN1 (0.45) MEN1KMT2ANPC1RAB9AAADAT
SCHEMBL25629827 0.86 MEN1 (0.41) MEN1KMT2ANPC1RAB9AAADAT
SCHEMBL21244412 0.84 MEN1 (0.43) MEN1KMT2ANPC1RAB9AAADAT
SCHEMBL29037035 0.84 KMT2A (0.43) MEN1KMT2ANPC1RAB9AAADAT
SCHEMBL19170474 0.78 MEN1 (0.52) MEN1KMT2ANPC1RAB9AAADAT
SCHEMBL21244847 0.75 PTGS2 (0.53) MEN1KMT2ANPC1RAB9AAADAT
SCHEMBL21245036 0.75 MEN1 (0.49) MEN1KMT2ANPC1RAB9AAADAT
SCHEMBL25629852 0.73 NPBWR1 (0.48) KDM4EALDH1A1MAPTALOX15CMA1
SCHEMBL17459011 0.72 MEN1 (0.49) MEN1KMT2ANPC1RAB9AAADAT
SCHEMBL27090763 0.71 MEN1 (0.46) MEN1KMT2ANPC1RAB9AAADAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4198037-A1 MACROCYCLES AS MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS THEREOF AND THEIR USE IN THE TREATMENT OF CYCSTIC FIBROSIS Vertex Pharmaceuticals Incorporated (US) 2023-06-21 — — EP disclosed
Send feedback